Malca Yonatan's most recent trade in Entera Bio Ltd was a trade of 28,509 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 15, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 28,509 | 28,509 | - | - | Stock Option (right to buy) | |
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 8,216 | 47,259 (0%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2024 | 8,639 | 39,043 (0%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2024 | 23,172 | 30,404 (0%) | 0% | 0 | Ordinary Shares, par value NIS 0.0000769 per share | |
Entera Bio Ltd | Malca Yonatan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 108,333 | 108,333 | - | - | Stock Option (right to buy) | |
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 89,041 | 89,041 | - | - | Stock Option (right to buy) | |
Entera Bio Ltd | Yonatan Malca | Director | Purchase of securities on an exchange or from another person at price $ 2.74 per share. | 13 Jan 2022 | 7,232 | 7,232 (0%) | 0% | 2.7 | 19,816 | Ordinary Shares, par value NIS 0.0000769 per share |
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 107,557 | 107,557 | - | - | Stock Option (right to buy) | |
Entera Bio Ltd | Yonatan Malca | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2022 | 35,852 | 35,852 | - | - | Stock Option (right to buy) |